256 filings
Page 5 of 13
8-K
9mt2z yu8mt
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
8-K
t6m4 wzcb9oc6m1qmzy
6 Nov 20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
7:55am
8-K
j7wdv3fga9v5
4 Nov 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
rtvylq4pg1fo
19 Oct 20
Regulation FD Disclosure
6:35am
8-K
0gwvgosce6zwiysy9
15 Sep 20
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors
4:45pm
424B5
icqpoge3g6 ub
10 Aug 20
Prospectus supplement for primary offering
4:05pm
8-K
6lrf1 o9c1z5nvb6
10 Aug 20
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights
4:05pm
EFFECT
n9ir17p2nc vr
10 Aug 20
Notice of effectiveness
12:15am
CORRESP
0wyl6h9eky sjgun
31 Jul 20
Correspondence with SEC
12:00am
CORRESP
s0erb 6fn82fmr2
27 Jul 20
Correspondence with SEC
12:00am
UPLOAD
tcvtv0w gkn
16 Jul 20
Letter from SEC
12:00am
8-K
4ro35
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
panrxa yyy
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
8kduhg8t wr0n8pjs
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm